| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/JCP.2010.087023 |
| P698 | PubMed publication ID | 21450752 |
| P2093 | author name string | Kosaku Nitta | |
| Takashi Takei | |||
| Ari Shimizu | |||
| Mitsuyo Itabashi | |||
| Takahito Moriyama | |||
| Shigeru Horita | |||
| Keiko Uchida | |||
| Yuki Tsuruta | |||
| P433 | issue | 6 | |
| P304 | page(s) | 504-509 | |
| P577 | publication date | 2011-03-30 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | The significance of caveolae in the glomeruli in glomerular disease | |
| P478 | volume | 64 |
| Q34143819 | A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversity |
| Q50884558 | Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy. |
| Q64104642 | Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells |
| Q90999576 | Caveolin-1 rs4730751 single-nucleotide polymorphism may not influence kidney transplant allograft survival |
| Q34718127 | Comprehensive investigation of the caveolin 2 gene: resequencing and association for kidney transplant outcomes |
| Q35568602 | Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation. |
| Q38911915 | Genetics of childhood steroid-sensitive nephrotic syndrome |
| Q91620438 | Immunoenzymatic Staining of Caveolin-1 in Formalin-Fixed Renal Graft Showing Chronic Antibody Mediated Rejection |
| Q36746042 | Loss of Epithelial Membrane Protein 2 Aggravates Podocyte Injury via Upregulation of Caveolin-1. |
| Q24297429 | Mutations in EMP2 cause childhood-onset nephrotic syndrome |
| Q37328835 | Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions. |
| Q89821419 | Role of Caveolin-1 in Diabetes and Its Complications |
Search more.